COVID-19 and g6pd deficiency in endemic areas of Plasmodium vivax malaria in Venezuela
In this class note, the authors present evidence on the risk that glucose-6-phosphate dehydrogenase deficiency has to coexist in the framework of the COVID-19 pandemic in the same country, such as Venezuela and Plasmodiun vivax malaria, in a compendium of information that will undoubtedly serve as t...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2021
- Institución:
- Pontificia Universidad Javeriana Cali
- Repositorio:
- Vitela
- Idioma:
- spa
- OAI Identifier:
- oai:vitela.javerianacali.edu.co:11522/513
- Acceso en línea:
- https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/1297
https://vitela.javerianacali.edu.co/handle/11522/513
- Palabra clave:
- Glucosa-6-fosfato deshidrogenasa
COVID-19
Malaria
Plasmodium vivax
Hemólisis
Programas de salud
Glucose-6-phosphate dehydrogenase,
COVID-19
Malaria
Plasmodium vivax
Hemolysis
Health programs
- Rights
- License
- Derechos de autor 2023 Salutem Scientia Spiritus
| Summary: | In this class note, the authors present evidence on the risk that glucose-6-phosphate dehydrogenase deficiency has to coexist in the framework of the COVID-19 pandemic in the same country, such as Venezuela and Plasmodiun vivax malaria, in a compendium of information that will undoubtedly serve as the basis for the proper design of health control programs, given that COVID-19 is an emerging disease without official inclusion in the previous existing health programs upon his appearance. |
|---|